B. Riley Financial, Inc. - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAF1. A total of 20 filers reported holding PDL BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
B. Riley Financial, Inc. ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q4 2016$72,000
+46.9%
74,000
+48.0%
0.05%
+54.8%
Q3 2016$49,000
+4.3%
50,0000.0%0.03%
+14.8%
Q2 2016$47,00050,0000.03%
Other shareholders
PDL BIOPHARMA INC shareholders Q4 2016
NameSharesValueWeighting ↓
Context Capital Management, LLC 4,420,000$3,547,0005.52%
Park West Asset Management LLC 28,535,000$22,846,0002.47%
ZAZOVE ASSOCIATES LLC 22,590,000$18,016,0000.85%
IRON Financial LLC 1,170,000$960,0000.82%
WHITEBOX ADVISORS LLC 14,716,000$11,782,0000.32%
AQR Arbitrage LLC 23,475,000$18,912,0000.21%
PRELUDE CAPITAL MANAGEMENT, LLC 1,500,000$1,208,0000.19%
Pinnacle Summer Investments, Inc. 16,672,000$916,0000.14%
WOLVERINE ASSET MANAGEMENT LLC 7,679,000$6,104,0000.13%
OAKTREE CAPITAL MANAGEMENT LP 8,296,000$6,595,0000.09%
View complete list of PDL BIOPHARMA INC shareholders